Navigation Links
Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
Date:12/21/2007

HORSHAM, Pa. and KENILWORTH, N.J., Dec. 21 /PRNewswire-FirstCall/ -- Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) today announced they have revised their 1998 distribution agreement regarding the development, commercialization and distribution of both REMICADE(R) (infliximab), an anti-tumor necrosis factor (anti-TNF) alpha therapy for chronic inflammatory disorders, and golimumab, Centocor's next-generation, human, anti-TNF alpha therapy, which is currently in Phase 3 trials. Effective upon regulatory approval of golimumab in the EU, the revised agreement will extend the duration of Schering-Plough's rights to exclusively market REMICADE in its current marketing territories outside the United States beyond 2014 to match the current duration of its exclusive marketing rights for golimumab product. Schering-Plough's marketing rights to both products will now extend for 15 years after the first golimumab commercial sale.

In addition, Centocor will receive a progressively increased share of profits on Schering-Plough's distribution of both products in the Schering-Plough marketing territory between 2010 and 2014, and remaining fixed thereafter for the remainder of the term.

The revised agreement will also allow Schering-Plough to independently develop and market golimumab for the Crohn's disease indication in its territories, with an option for Centocor to participate in the program.

The parties have also agreed to utilize an autoinjector device developed by Centocor affiliate Cilag GmbH International in the commercialization of golimumab in their respective territories and have further agreed to share the autoinjector development costs. The autoinjector would allow patients to self-administer golimumab subcu
'/>"/>

SOURCE Schering-Plough Corporation; Centocor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. PreViser Launches New Website and Enhanced Version of Its Oral Disease and Risk Assessment Software
10. NUCRYST and Smith & Nephew Revise Agreements
11. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2015)... (PRWEB) May 02, 2015 Kare Visits LLC. ... support for busy caregivers. Kare Visits offers relief for ... assisted living facilities. According to the Caregiver Action ... an average of 20 hours a week caring for an ... the cost to hire a nurse, a caregiver is now ...
(Date:5/1/2015)... Texas (PRWEB) May 02, 2015 IDLife ... Texas, is proud to announce the addition of its ... Widerstrom is a life long athlete, growing up in ... passion after college by becoming a personal trainer and ... been the face of several TV shows highlighting her ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Royal River ... Freeport, Maine, reports on a new study that found ... joint swelling and improved physical function as well as ... severe osteoarthritis of the knee. , The report is ... Insights for Well Being® ,” which Royal River Natural ...
(Date:5/1/2015)... Hope For The Warriors® thanks All American ... Warriors® and military families. All American Ford presented two ... Warriors®, a national nonprofit dedicated to restoring a sense ... for our service members and our military families. , ... and matched small autograph fee from fans and presented ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Today the United ... expanding its fundraising efforts to help protect the rights of ... new program support country added since Girl Up began almost ... campaign aimed at supporting adolescent girls in the Rajasthan region ... Up has supported the advancement of adolescent girls in Guatemala, ...
Breaking Medicine News(10 mins):Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3
... in to help with care, researchers say , SUNDAY, April ... chronically ill older people in the United States live alone, ... how to take care of their parents and relatives, a ... to significantly help many patients with chronic illness manage their ...
... ... interactive feature, Keilhauer,s new microsite for Beam Seating makes specifying beam seating an easy ... ... Beam seating expand the original series to such an extent it can hardly be ...
... ... addictions, S.A. Lifeline Foundation has launched a brand new website that offers assistance and hope ... Lehi, UT ... of porn addiction is on a steady rise. Knowing this, Utah based S.A. ...
... ... proud to announce the unveiling of its brand new internet property, ... the American Consumer. TouchstoneSaunas.com offers premium quality Infrared Saunas designed ... from the highest quality materials to provide many years of reliable ...
... as the goal, while females hope to ,feel good, ... run marathons to feel good while men run for competition ... The research included 507 female and 399 male first-time marathoners, ... to reveal the participants, motivation for taking part in the ...
... ... Daniel R. Tishman to Speak on Panel, ‘Cost-Effective Sustainable Design and Development,’ on ... ... R. Tishman, Chairman and CEO of New York-based Tishman Construction Corporation, will participate in ...
Cached Medicine News:Health News:1 in 4 Chronically Ill Elderly Lives Alone 2Health News:Keilhauer's Expanded Beam Seating Launches With its Own Microsite 2Health News:Keilhauer's Expanded Beam Seating Launches With its Own Microsite 3Health News:S.A. Lifeline Foundation Offers New and Improved Website for Those with Pornography Addictions 2Health News:Touchstone Saunas Goes Online to Provide Premium Quality Infrared Saunas 2Health News:Are Male Marathoners More Competitive Than Women? 2Health News:Tishman Construction – World Leader in Sustainable Real Estate Development and Project Management – Exhibits at Abu Dhabi Cityscape 2Health News:Tishman Construction – World Leader in Sustainable Real Estate Development and Project Management – Exhibits at Abu Dhabi Cityscape 3Health News:Tishman Construction – World Leader in Sustainable Real Estate Development and Project Management – Exhibits at Abu Dhabi Cityscape 4Health News:Tishman Construction – World Leader in Sustainable Real Estate Development and Project Management – Exhibits at Abu Dhabi Cityscape 5
(Date:5/1/2015)... 01, 2015 /PRNewswire/ --Research and Markets ( ... Clinical Chemistry Analyzer Market by Product, by End-Users - Forecast ... American Clinical Chemistry Analyzers market is estimated to grow at ... as the U.S., Canada , ... of Americas (RoA) are covered in this report. ...
(Date:5/1/2015)... CAMBRIDGE, Mass. , May 1, 2015  Portal ... innovative drug delivery systems, announced today that Robert ... Hunter , Ph.D., University of Auckland Distinguished Professor have ... are thrilled to welcome two esteemed biotechnology leaders, Professor ... , to our team," said Dr. Patrick Anquetil ...
(Date:5/1/2015)...  CytRx Corporation (CYTR), a biopharmaceutical research and ... results for the three months ended March 31, ... and upcoming milestones for its clinical development programs. ... early months of 2015, including the announcement of ... in patients with soft tissue sarcoma, and positive ...
Breaking Medicine Technology:Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... Niiki Pharma Inc. announced interim results from the ongoing ... NKP-1339 is a first-in-class transferrin targeted small molecule that ... and a tumor survival factor. NKP-1339 ... in patients with metastatic solid tumors resistant to standard ...
... height, their exact measurements have made seca the world,s ... company is taking a giant step forward with its ... The new seca 360 wireless system resolves ... of weight, height and other general health parameters.  This ...
Cached Medicine Technology:Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339 2Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339 3Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339 4seca 360 wireless - The New Era of Measuring and Weighing 2
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
... Oxygen flowmeter with a Lexan®inner calibrated flow ... and manufacturing defects. A wide range of ... Also available with all popular inlet connections, ... double unit configurations. Our extra large knob ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: